Dapsone 25mg
NDC 85185-104, Dapsone 25mg, tablet, from Solis Pharmaceuticals Inc..
- Product NDC
- 85185-104
- Status
- Listed
- Labeler
- Solis Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203887
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85185-104 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPSONE25 mg/1
Pharmacologic classes
Sulfone [EPC]; Sulfones [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85185-104-01 | 85185010401 | 30 TABLET in 1 BOTTLE (85185-104-01) |
| 85185-104-02 | 85185010402 | 100 TABLET in 1 BOTTLE (85185-104-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/50204029-4c29-5b8d-e063-6394a90af383
Use it
Look up 85185-104 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85185-104 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85185-104. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.